MacroGenics, Inc. (NASDAQ: MGNX) had its price target lowered by analysts at HC Wainwright from $4.00 to $2.00. They now have a "neutral" rating on the stock.
MacroGenics, Inc. (NASDAQ: MGNX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
MacroGenics Provides Update on Corporate Progress and 2024 Financial Results
MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call
MacroGenics to Participate in Upcoming Investor Conferences